Drug Shortage Report for PDP-AMANTADINE HYDROCHLORIDE SYRUP
Report ID | 68895 |
Drug Identification Number | 02022826 |
Brand name | PDP-AMANTADINE HYDROCHLORIDE SYRUP |
Common or Proper name | AMANTADINE |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | AMANTADINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SYRUP |
Route of administration | ORAL |
Packaging size | 500mL |
ATC code | N04BB |
ATC description | DOPAMINERGIC AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2018-11-29 |
Actual start date | 2018-11-23 |
Estimated end date | 2019-01-09 |
Actual end date | 2019-01-07 |
Shortage status | Resolved |
Updated date | 2019-01-21 |
Company comments | pdp-AMANTADINE HCl 100mg CAPS 100 remain available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2019-01-21 | French | Compare |
v6 | 2019-01-21 | English | Compare |
v5 | 2018-12-28 | French | Compare |
v4 | 2018-12-28 | English | Compare |
v3 | 2018-12-07 | French | Compare |
v2 | 2018-12-07 | English | Compare |
v1 | 2018-12-07 | English | Compare |
Showing 1 to 7 of 7